Within the next ten odd days, Jeff Brown, one of the world’s leading investment gurus, futurists, and technology experts, is all set to go live with his latest presentation, wherein he will share some insights into what he thinks is the next best stock investment opportunities available to investors in the market today. His latest offering, this time around, is called “#1 Timed Stock”. It presents people with an untapped market avenue that he believes can rise by more than 23,000% in the near future.
In his view, now and then, the market presents investors with a possibility that in advanced terms is referred to as ‘Timed Stocks.’ Because of certain regulatory impositions placed by the Federal Government, they are equities that come with a preset countdown “timer” attached to their value, thus allowing for their value to surge by mammoth proportions within a concise time window.
According to Jeff, over the years, he has tracked hundreds of these launches. On March 18, at 8 pm ET, he will again do a live online presentation, pointing out to his backers several such opportunities validated by market data.
A closer look at Timed Stocks Final Countdown
Many investors may not be aware that nearly one in every 680 stocks can be classified as a “Timed Stock” because they fall under the above-stated regulatory standards laid out by the Federal Government. According to Jeff Brown, these options are all set to rise in a big way this year, especially as markets worldwide continue to reel from the devastating effects of the COVID-19 pandemic.
According to Brown, investors who can recognize this opportunity will be able to:
- Incur profits that they could have never even conceived off even remotely in the past.
- Draw returns in a manner that is not only quick but also sustainable.
- Rake in profits of up 23,200% in a single day.
Core aspects of Timed Stocks Final Countdown
Unique Trading Strategies
As pointed out in an earlier section, the ‘Timed Stocks Final Countdown’ program is designed to help users learn about various Federal Government regulations that classify certain stocks as being “timed,” thus allowing their prices to rise almost exponentially within short time frames. Furthermore, as part of the system, Brown will help his clients identify these options and tell the difference between a regular and timed stock.
Full 30-day Timed Stock calendar
As the name suggests, Brown’s stock calendar will provide users with the opportunity to pick and choose from several timed stock options along with the exact dates as to when these offerings will likely rise in value.
Highly Industry Specific
Per details made available online by Brown, most of the stocks he will be presenting as part of his online seminar on the 18th of this month are related to the Biotech space. In his own words, these offerings come with a preset timer attached to them, and the exact moment when the timer hits zero, these stocks stand to surge in an almost inconceivable manner.
Why biotech stocks?
It is no secret that since the onset of the coronavirus pandemic last March, the world has seen its attention move towards the vaccine R&D market in a big way. In this regard, any positive news related to a positive preclinical/clinical trial can send biotech companies’ stock value up in a big way.
In this regard, 2021 seems poised to be one of the biggest and most profitable years for timed stocks. Many biotech firms are already delivering gains quite akin to how many assets within the crypto market have been performing.
According to Brown, he has spent a better half of the last half-decade or refines his market strategies precisely for this kind of bullish market. In his view, if capitalized upon, timed stocks present investors with the opportunity of a lifetime, allowing them to accelerate their gains in a manner that has never been possible or even witnessed before.
Furthermore, Brown believes that the last 12 odd months have seen the shares of many medical research firms soaring by 1,000%, especially as an increasing number of these companies have started to integrate novel tech domains such as AI or Machine Learning into their existing operational protocols. This has resulted in cross-industry investments happening rapidly, pushing the future valuation of such inter-disciplinary biotech firms even higher.
A closer look at ‘timed stocks’
With governments worldwide scampering to get vaccines out for the masses, the time window in which new FDA-approved drugs can enter the market is becoming increasingly narrow. In this regard, there is more profit to be made than ever before within this yet burgeoning space.
According to Brown’s estimates, the American government will issue a mandate around getting therapies approved for public use. When the timer hits zero for such stocks’ companies, their prices can skyrocket not within days but seemingly in a matter of hours.
Additionally, one of the best parts about this entire proposition is that these relatively small companies are still quite small and unknown, leaving them off the radar of many wealth managers, hedge funds, etc. Thus, they present investors with little pockets to capitalize on and maximize their wealth in a manner that has mostly never been seen before.
Last but not least, it bears mentioning that in the past, timed stocks have surged by 931%… 1,313 and 1,526%. If that wasn’t eye-popping enough, the one-timed stock increased by an insane 84,900% within just 24 hours recently.
When is Jeff Brown’s Timed Stocks: Final Countdown Summit going to air?
As highlighted in an earlier section, the Timed Stocks: Final Countdown Summit is scheduled to go live on Thursday, March 18, at 8 p.m. ET. Since the event has limited spacing, it is of utmost importance that users sign up sooner rather than later to not miss out on this fantastic window of opportunity.
To sign up for this program, all one has to do is go to the official company website and follow the simple instructions that have been outlined there. Users will need to enter their email addresses and, after completing the signup process, will be required to provide a few personal details. Furthermore, it should be pointed out that individuals possessing a US mobile phone number will be afforded the chance of gaining free ‘VIP access.’
In this regard, VIP members will have the chance of gaining access to Jeff Brown’s latest report called ‘The Top 5 Biotech IPOs of 2021’ before it is made available to anyone else. Also, it is worth noting that the report is valued at $199 but will be provided to VIP guests free of cost.
So who exactly is Jeff Brown?
After going through all the above-stated hype surrounding Jeff’s offering, as mentioned earlier, many of our readers would surely be interested in learning about the man himself. Over the years, Jeff has become a force to be reckoned with, especially across the global investment landscape.
As per his biography that is currently available online, Brown received his bachelor’s degree in aeronautical and astronautical engineering from Purdue University in Indiana. For those unaware, the program is touted to be one of the best within this space and has been attended by 16 astronauts to date before they left on their space missions.
However, for the last three odd decades, Jeff has worked extensively within the tech industry, dabbling in things ranging from semiconductors to digital broadcasting to security. Not only that, but he has also served as an angel investor for a large number of early startups. He has facilitated over 145 private deals amongst the movers and shakers of the global financial landscape.
Some of Jeff’s other credentials that are worthy of note include:
He is a member of the Chamber of Digital Commerce, a globally recognized group of prominent crypto and blockchain technologists.
Jeff has briefed U.S. lawmakers on Capitol Hill regarding blockchain tech, cryptocurrencies, and decentralized ledgers in the past.
Back in 2019, he founded a free newsletter known as the ‘The Bleeding Edge.’ Through this offering, he has helped countless investors stay abreast with the latest happenings taking place in the world of digital tech. It is worth highlighting that within just 24 months, the e-letter has accumulated more than a million regular readers.
Lastly, in addition to all of his market knowledge and investment prowess, readers need to know that Brown is regularly invited to many high-profile events. For example, a couple of years back (i.e., 2019), he was invited to be a part of a closed-door biotech conference at MIT. Not only that, the same year, he advised a special group of U.S. senators regarding CBDCs. He did all of this while supervising Brownstone Research’s three essential editorial wings i.e., The Near Future Report, Exponential Tech Investor, and Early Stage Trader.
What is ‘Early Stage Trader’?
When one signs up for the Timed Stocks: Final Countdown Summit, investors will be briefed about the Early Stage Trader offering, which in its most basic sense can be thought of as an investment research service through which Jeff Brown can disseminate his market knowledge regarding a whole host of small, untapped biotech stocks (that are currently riding high on the ongoing medical research trend).
Early Stage Trader’s goal is to help users get hands-on experience trading various small stocks and teach people about the hidden opportunities that are routinely made available to investors if they choose to recognize them in a timely manner.
Upon signing up, users will be provided with streamlined access to the following products:
- The Early Stage Trader Manifesto: This guide serves as the core of the program, outlining all of the various ways this offering works. As part of the system, users will also be provided with details regarding Jeff and his team and how interested individuals can explore many different unchartered market spaces while minimizing their risks.
- Twelve newsletters: As part of the offering, users will be provided with a detailed newsletter each month that will contain information regarding early-stage startups that users can invest in to maximize their gains.
- Regular Updates: An underrated facet of ‘Early Stage Trader’ is that it dishes out periodic updates regarding the various stock options that Brown is bullish on.
- Urgent Alerts: In case there is an emergency type situation where users may need to liquidate their holdings (or other such scenarios), Brown and his team will send out timely updates, allowing investors to take timely action.
Timed Stocks Final Countdown Pricing and Refunds
At press time, access to the Early Stage Trader system is available online for a base sum of just $2,500. In this regard, it should be mentioned that typically such an offering is provided to people anywhere above $10k.
Also, each subscription is backed by a ninety-day satisfaction guarantee, which means that if users are not happy with Brown’s investment advice, they can choose to cancel their memberships and obtain a full refund. The money is credited back to the user’s source bank account within a matter of 3-5 working days. Additionally, users can choose to get a credit option and use their refunded money to purchase any other service that Brownstone Research may have up for grabs.
Finally, payments can be facilitated via a host of safe and secure means, including PayPal, Mastercard, Visa, AMEX, JCB, and Discover. Interested consumers can visit the Brownstone Research page and enter their email address to sign up for access to the Early Stage Trader system on their official website.